zepbound and tirzepatide (zepbound) 12-Week Weight Loss Program at Bethany Clinic, NJ Zepbound now available in multi-dose

Semasize Plus 2.4mg Injection (1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab) is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight

Key Takeaways Mounjaro is the brand name for tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes management and, under the name Zepbound, for weight loss

Weight loss injections are a method of administering medications subcutaneously

When compared to insulin users, semaglutide reduced dementia risk by 46%

[1] [2] The medication comes in a pre-filled, single-use pen device designed to simplify administration for patients